Nvidia (NVDA) Shares Fall to a Year-to-Date Low

FXOpen

As the Nvidia (NVDA) share price chart shows, the stock fell below $177 during yesterday’s session, marking its lowest level since the start of 2026.

Negative market sentiment is largely driven by uncertainty surrounding supplies to China. According to the Financial Times, Nvidia’s sales of H200 chips to China are still awaiting final approval from US authorities.

Yesterday’s statement from AMD, noting that the scale of its own shipments to China remains uncertain, reinforced these concerns and added further pressure to Nvidia shares. Previously, NVDA had been supported by expectations that deliveries of H200 chips to Chinese partners would begin in early 2026.

In addition, some media reports suggest that the stock is facing extra pressure from news of delayed investment in OpenAI, which is reportedly exploring alternative suppliers.

Technical Analysis of the Nvidia (NVDA) Chart

On 23 December, when analysing NVDA price action, we:

→ reaffirmed the long-term ascending channel, which remains intact;
→ suggested that bulls might attempt to break out of the corrective pattern (shown in red) in order to reach the channel median.

As expected (indicated by the black arrow), the price reached this target. However, January’s price behaviour offers little evidence that the uptrend has resumed with renewed strength.

Moreover, the red arrows highlight several bearish signals:

→ the median acted as clear resistance;
→ the 30 January peak (the highest level since the start of the year) formed with a long upper shadow, resulting in a false break of the previous high — a classic “bull trap”.

While bearish momentum appears to be in control, it is worth noting that:

→ the break below the 20 January low could also prove to be false;
→ the lower boundary of the channel, which has acted as key support for many months, is nearby.

Taking all of this into account, it is reasonable to assume that NVDA may find a period of consolidation in the lower quarter of the channel. A potential catalyst for the next major move could be the company’s earnings release scheduled for 25 February.

Buy and sell stocks of the world's biggest publicly-listed companies with CFDs on FXOpen’s trading platform. Open your FXOpen account now or learn more about trading share CFDs with FXOpen.

This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.

Stay ahead of the market!

Subscribe now to our mailing list and receive the latest market news and insights delivered directly to your inbox.

forex

Share CFD Trading with FXOpen

Share CFD Trading with FXOpen

Experience ECN technology for deep liquidity and light-speed trade execution

  • Trade with tight spreads
  • Take advantage of low commissions
  • Choose from 4 trading platforms: MT4, MT5, TradingView, or TickTrader
Learn more

Latest articles

Forex Analysis

CAD/JPY: The Yen's Most Historic Move in 30 Years Meets a Fragile Support

Two central banks are heading in genuinely opposite directions this week, and the tension is unmistakable. The Bank of Canada held rates steady at 2.25% on September 2, with a mildly hawkish tilt as policymakers acknowledged a broadening economic

Forex Analysis

USD/JPY and USD/CAD Await Key Fed Decision

The US dollar is consolidating against the yen and Canadian dollar ahead of the key event of the week — the Federal Reserve meeting. The Fed is widely expected to raise its policy rate by 25 basis points to a range

Shares

UnitedHealth: Fundamentals Are Healing, Now the Chart Must Agree

UnitedHealth finds itself in a genuinely split narrative right now, trading near $388, down about 15.9% from its 52-week high, even as the fundamental picture keeps improving. Q2 earnings beat expectations, with revenue of $112.03 billion, and the

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 60% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.